These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 28052319)

  • 1. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.
    Castro-Marrero J; Sáez-Francàs N; Santillo D; Alegre J
    Br J Pharmacol; 2017 Mar; 174(5):345-369. PubMed ID: 28052319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.
    Smith ME; Haney E; McDonagh M; Pappas M; Daeges M; Wasson N; Fu R; Nelson HD
    Ann Intern Med; 2015 Jun; 162(12):841-50. PubMed ID: 26075755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
    Mitchell WM
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):755-70. PubMed ID: 27045557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.
    Morris MC; Cooney KE; Sedghamiz H; Abreu M; Collado F; Balbin EG; Craddock TJA; Klimas NG; Broderick G; Fletcher MA
    Clin Ther; 2019 Apr; 41(4):656-674.e4. PubMed ID: 30929860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.
    Strayer DR; Carter WA; Stouch BC; Stevens SR; Bateman L; Cimoch PJ; Lapp CW; Peterson DL; ; Mitchell WM
    PLoS One; 2012; 7(3):e31334. PubMed ID: 22431963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.
    Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Mair JL; Ormerod J; Carless D; Hilliard N; Meach R; Ingram J; Sculthorpe NF
    J Transl Med; 2023 Oct; 21(1):720. PubMed ID: 37838675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Smith MEB; Nelson HD; Haney E; Pappas M; Daeges M; Wasson N; McDonagh M
    Evid Rep Technol Assess (Full Rep); 2014 Dec; (219):1-433. PubMed ID: 30313001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.
    Campagnolo N; Johnston S; Collatz A; Staines D; Marshall-Gradisnik S
    J Hum Nutr Diet; 2017 Jun; 30(3):247-259. PubMed ID: 28111818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
    Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
    Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
    Kim DY; Lee JS; Park SY; Kim SJ; Son CG
    J Transl Med; 2020 Jan; 18(1):7. PubMed ID: 31906979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.
    Chambers D; Bagnall AM; Hempel S; Forbes C
    J R Soc Med; 2006 Oct; 99(10):506-20. PubMed ID: 17021301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Strayer DR; Young D; Mitchell WM
    PLoS One; 2020; 15(10):e0240403. PubMed ID: 33119613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD003200. PubMed ID: 28444695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD003200. PubMed ID: 27995604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Jun; (6):CD003200. PubMed ID: 27339435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003200. PubMed ID: 25674924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Feb; 2():CD003200. PubMed ID: 26852189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review.
    Alraek T; Lee MS; Choi TY; Cao H; Liu J
    BMC Complement Altern Med; 2011 Oct; 11():87. PubMed ID: 21982120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing specialist medical care with specialist medical care plus the Lightning Process for chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME): study protocol for a randomised controlled trial (SMILE Trial).
    Crawley E; Mills N; Hollingworth W; Deans Z; Sterne JA; Donovan JL; Beasant L; Montgomery A
    Trials; 2013 Dec; 14():444. PubMed ID: 24370208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.